Medtronic plc Repayments of Long-Term Debt
Medtronic plc (MDT) reported Repayments of Long-Term Debt of $0 for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-09-03
- Medtronic plc repayments of long-term debt for the quarter ending 2026-07-31 was $0.00, a 100.00% decline year-over-year.
- Medtronic plc repayments of long-term debt for the quarter ending 2026-04-24 was $0.00.
- Medtronic plc repayments of long-term debt for the quarter ending 2026-01-23 was $0.00.
- Medtronic plc repayments of long-term debt for the quarter ending 2025-10-24 was $1.77B.
- Medtronic plc repayments of long-term debt for fiscal 2026 was $2.93B.
- Medtronic plc repayments of long-term debt for fiscal 2025 was $0.00.
- Medtronic plc repayments of long-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Medtronic plc repayments of long-term debt for fiscal 2023 was $6.01B, a 601100.00% increase from fiscal 2022.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-07-31 | $0.00 10-Q · filed 2026-09-03 | $0.00 derived: sum of 2 quarters · filed 2026-09-03 | $0.00 derived: sum of 3 quarters · filed 2026-09-03 | $1.77B derived: sum of 4 quarters · filed 2026-09-03 |
| 2026-04-24 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $0.00 derived: sum of 2 quarters · filed 2026-06-18 | $1.77B derived: sum of 3 quarters · filed 2026-06-18 | $2.93B 10-K · filed 2026-06-18 |
| 2026-01-23 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-24 | $1.77B derived: sum of 2 quarters · filed 2026-02-24 | $2.93B 10-Q · filed 2026-02-24 | $2.93B derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-10-24 | $1.77B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-25 | $2.93B 10-Q · filed 2025-11-25 | $2.93B derived: sum of 3 quarters · filed 2026-09-03 | $2.93B derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-07-25 | $1.16B 10-Q · filed 2026-09-03 | $1.16B derived: sum of 2 quarters · filed 2026-09-03 | $1.16B derived: sum of 3 quarters · filed 2026-09-03 | $1.16B derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-04-25 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $0.00 derived: sum of 2 quarters · filed 2026-06-18 | $0.00 derived: sum of 3 quarters · filed 2026-06-18 | $0.00 10-K · filed 2026-06-18 |
| 2025-01-24 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 10-Q · filed 2026-02-24 | $0.00 derived: sum of 4 quarters · filed 2026-06-18 |
| 2024-10-25 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-25 | $0.00 10-Q · filed 2025-11-25 | $0.00 derived: sum of 3 quarters · filed 2026-06-18 | $0.00 derived: sum of 4 quarters · filed 2026-06-18 |
| 2024-07-26 | $0.00 10-Q · filed 2025-08-26 | $0.00 derived: sum of 2 quarters · filed 2026-06-18 | $0.00 derived: sum of 3 quarters · filed 2026-06-18 | $0.00 derived: sum of 4 quarters · filed 2026-06-18 |
| 2024-04-26 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $0.00 derived: sum of 2 quarters · filed 2026-06-18 | $0.00 derived: sum of 3 quarters · filed 2026-06-18 | $0.00 10-K · filed 2026-06-18 |
| 2024-01-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 10-Q · filed 2024-02-27 | $2.93B derived: sum of 4 quarters · filed 2025-06-20 |
| 2023-10-27 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-30 | $0.00 10-Q · filed 2023-11-30 | $2.93B derived: sum of 3 quarters · filed 2025-06-20 | $3.70B derived: sum of 4 quarters · filed 2025-06-20 |
| 2023-07-28 | $0.00 10-Q · filed 2023-08-31 | $2.93B derived: sum of 2 quarters · filed 2025-06-20 | $3.70B derived: sum of 3 quarters · filed 2025-06-20 | $3.70B derived: sum of 4 quarters · filed 2025-06-20 |
| 2023-04-28 | $2.93B derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $3.70B derived: sum of 2 quarters · filed 2025-06-20 | $3.70B derived: sum of 3 quarters · filed 2025-06-20 | $6.01B 10-K · filed 2025-06-20 |
| 2023-01-27 | $772.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-27 | $772.00M derived: sum of 2 quarters · filed 2024-02-27 | $3.08B 10-Q · filed 2024-02-27 | $3.08B derived: sum of 4 quarters · filed 2024-06-20 |
| 2022-10-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-30 | $2.31B 10-Q · filed 2023-11-30 | $2.31B derived: sum of 3 quarters · filed 2024-06-20 | $2.31B derived: sum of 4 quarters · filed 2024-06-20 |
| 2022-07-29 | $2.31B 10-Q · filed 2023-08-31 | $2.31B derived: sum of 2 quarters · filed 2024-06-20 | $2.31B derived: sum of 3 quarters · filed 2024-06-20 | $2.31B derived: sum of 4 quarters · filed 2024-06-20 |
| 2022-04-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-20 | $0.00 derived: sum of 2 quarters · filed 2024-06-20 | $0.00 derived: sum of 3 quarters · filed 2024-06-20 | $1.00M 10-K · filed 2024-06-20 |
| 2022-01-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $1.00M 10-Q · filed 2023-03-01 | $917.00M derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-10-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-01 | $1.00M 10-Q · filed 2022-12-01 | $917.00M derived: sum of 3 quarters · filed 2023-06-22 | $1.03B derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-07-30 | $1.00M 10-Q · filed 2022-09-01 | $917.00M derived: sum of 2 quarters · filed 2023-06-22 | $1.03B derived: sum of 3 quarters · filed 2023-06-22 | $7.36B derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-04-30 | $916.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | $1.03B derived: sum of 2 quarters · filed 2023-06-22 | $7.36B derived: sum of 3 quarters · filed 2023-06-22 | $7.37B 10-K · filed 2023-06-22 |
| 2021-01-29 | $115.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-03 | $6.44B derived: sum of 2 quarters · filed 2022-03-03 | $6.45B 10-Q · filed 2022-03-03 | $6.96B derived: sum of 4 quarters · filed 2022-06-23 |
| 2020-10-30 | $6.33B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-02 | $6.34B 10-Q · filed 2021-12-02 | $6.84B derived: sum of 3 quarters · filed 2022-06-23 | $6.85B derived: sum of 4 quarters · filed 2022-06-23 |
| 2020-07-31 | $11.00M 10-Q · filed 2021-09-02 | $515.00M derived: sum of 2 quarters · filed 2022-06-23 | $527.00M derived: sum of 3 quarters · filed 2022-06-23 | $1.09B derived: sum of 4 quarters · filed 2022-06-23 |
| 2020-04-24 | $504.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | $516.00M derived: sum of 2 quarters · filed 2022-06-23 | $1.07B derived: sum of 3 quarters · filed 2022-06-23 | $6.11B 10-K · filed 2022-06-23 |
| 2020-01-24 | $12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-05 | $571.00M derived: sum of 2 quarters · filed 2021-03-05 | $5.61B 10-Q · filed 2021-03-05 | $13.53B derived: sum of 4 quarters · filed 2021-06-25 |
| 2019-10-25 | $559.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-03 | $5.59B 10-Q · filed 2020-12-03 | $13.51B derived: sum of 3 quarters · filed 2021-06-25 | $13.53B derived: sum of 4 quarters · filed 2021-06-25 |
| 2019-07-26 | $5.04B 10-Q · filed 2020-09-03 | $12.95B derived: sum of 2 quarters · filed 2021-06-25 | $12.97B derived: sum of 3 quarters · filed 2021-06-25 | $12.97B derived: sum of 4 quarters · filed 2021-06-25 |
| 2019-04-26 | $7.92B derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-25 | $7.93B derived: sum of 2 quarters · filed 2021-06-25 | $7.94B derived: sum of 3 quarters · filed 2021-06-25 | $7.95B 10-K · filed 2021-06-25 |
| 2019-01-25 | $12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-28 | $17.00M derived: sum of 2 quarters · filed 2020-02-28 | $29.00M 10-Q · filed 2020-02-28 | $3.23B derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-10-26 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-03 | $17.00M 10-Q · filed 2019-12-03 | $3.22B derived: sum of 3 quarters · filed 2020-06-19 | $3.23B derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-07-27 | $12.00M 10-Q · filed 2019-08-30 | $3.21B derived: sum of 2 quarters · filed 2020-06-19 | $3.22B derived: sum of 3 quarters · filed 2020-06-19 | $7.37B derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-04-27 | $3.20B derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-19 | $3.21B derived: sum of 2 quarters · filed 2020-06-19 | $7.36B derived: sum of 3 quarters · filed 2020-06-19 | $7.37B 10-K · filed 2020-06-19 |
| 2018-01-26 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-01 | $4.16B derived: sum of 2 quarters · filed 2019-03-01 | $4.17B 10-Q · filed 2019-03-01 | $4.67B derived: sum of 4 quarters · filed 2019-06-21 |
| 2017-10-27 | $4.15B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-29 | $4.16B 10-Q · filed 2018-11-29 | $4.66B derived: sum of 3 quarters · filed 2019-06-21 | $4.77B derived: sum of 4 quarters · filed 2019-06-21 |
| 2017-07-28 | $8.00M 10-Q · filed 2018-08-31 | $510.00M derived: sum of 2 quarters · filed 2019-06-21 | $619.00M derived: sum of 3 quarters · filed 2019-06-21 | $854.00M derived: sum of 4 quarters · filed 2019-06-21 |
| 2017-04-28 | $502.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-21 | $611.00M derived: sum of 2 quarters · filed 2019-06-21 | $846.00M derived: sum of 3 quarters · filed 2019-06-21 | $863.00M 10-K · filed 2019-06-21 |
| 2017-01-27 | $109.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-02 | $344.00M derived: sum of 2 quarters · filed 2018-03-02 | $361.00M 10-Q · filed 2018-03-02 | $3.88B derived: sum of 4 quarters · filed 2018-06-22 |
| 2016-10-28 | $235.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-04 | $252.00M 10-Q · filed 2017-12-04 | $3.77B derived: sum of 3 quarters · filed 2018-06-22 | $3.78B derived: sum of 4 quarters · filed 2018-06-22 |
| 2016-07-29 | $17.00M 10-Q · filed 2017-09-01 | $3.54B derived: sum of 2 quarters · filed 2018-06-22 | $3.54B derived: sum of 3 quarters · filed 2018-06-22 | $4.14B derived: sum of 4 quarters · filed 2018-06-22 |
| 2016-04-29 | $3.52B derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-22 | $3.52B derived: sum of 2 quarters · filed 2018-06-22 | $4.13B derived: sum of 3 quarters · filed 2018-06-22 | $5.13B 10-K · filed 2018-06-22 |
| 2016-01-29 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-03 | $608.00M derived: sum of 2 quarters · filed 2017-03-03 | $1.61B 10-Q · filed 2017-03-03 | $2.87B derived: sum of 4 quarters · filed 2017-06-27 |
| 2015-10-30 | $604.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-05 | $1.61B 10-Q · filed 2016-12-05 | $2.86B derived: sum of 3 quarters · filed 2017-06-27 | $2.87B derived: sum of 4 quarters · filed 2017-06-27 |
| 2015-07-31 | $1.00B 10-Q · filed 2016-09-07 | $2.26B derived: sum of 2 quarters · filed 2017-06-27 | $2.27B derived: sum of 3 quarters · filed 2017-06-27 | $2.27B derived: sum of 4 quarters · filed 2017-06-27 |
| 2015-04-24 | $1.25B derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-27 | $1.26B derived: sum of 2 quarters · filed 2017-06-27 | $1.26B derived: sum of 3 quarters · filed 2017-06-27 | $1.27B 10-K · filed 2017-06-27 |
| 2015-01-23 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-09 | $10.00M derived: sum of 2 quarters · filed 2016-03-09 | $13.00M 10-Q · filed 2016-03-09 | |
| 2014-10-24 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-09 | $7.00M 10-Q · filed 2015-12-09 | ||
| 2014-07-25 | $3.00M 10-Q · filed 2015-09-09 | |||
| 2014-04-25 | $565.00M 10-K · filed 2016-06-28 | |||
| 2013-04-26 | $2.21B 10-K · filed 2015-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |